Economics Faculty Database
Economics
Arts & Sciences
Duke University

 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

Research Interests for David B. Ridley

Research Interests:

David Ridley is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business. He is also the Faculty Director of Duke's Health Sector Management program. In his research, David examines innovation and pricing, especially in health care. He was the lead author of the paper proposing the priority review voucher program The voucher program became law in the U.S. in 2007 and the market price of vouchers has been more than $100 million. David has published in economics journals (American Economic Journal: Economic Policy), medical journals (Journal of the American Medical Association), and scientific journals (Nature Reviews Drug Discovery). David teaches in the daytime MBA and executive MBA programs. He received a PhD in economics from Duke University in 2001.

Keywords:
Biotechnology, Drug Approval, Drug Costs, Drug Industry, Economics, Pharmaceutical, Elasticity, Health Care Costs, Health Care Economics and Organizations, Health Care Reform, Health Care Sector, Health Policy, Health Services Research, Innovation, Market entry, Patents as Topic, Prescription Fees, Pricing, Product Surveillance, Postmarketing, World Health Organization
Areas of Interest:

Health Economics
Industrial Organization
Strategy

Recent Publications   (search)
  1. Ridley, DB; Lasanta, AM; Storer Jones, F; Ridley, SK, European priority review vouchers for neglected disease product development., BMJ global health, vol. 9 no. 1 (January, 2024), pp. e013686, BMJ [doi[abs]
  2. Liebman, E; Lawler, EC; Dunn, A; Ridley, DB, Consequences of a shortage and rationing: Evidence from a pediatric vaccine., Journal of health economics, vol. 92 (December, 2023), pp. 102819, Elsevier BV [doi[abs]
  3. Cuddy, E; Lu, YP; Ridley, DB, FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 Levels., Health affairs (Project Hope), vol. 42 no. 12 (December, 2023), pp. 1758-1766 [doi[abs]
  4. Ridley, DB; Ganapathy, P; Kettler, HE, ​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access., Health affairs (Project Hope), vol. 40 no. 8 (August, 2021), pp. 1243-1251 [doi[abs]
  5. Ridley, DB; Lee, CY, Does medicare reimbursement drive up drug launch prices?, Review of Economics and Statistics, vol. 102 no. 5 (December, 2020), pp. 980-993 [doi[abs]

Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login